In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury

Biochemical and Biophysical Research Communications

Volumn 422, Issue 4, 2012, Pages 539-545

  Yu, Jiong ^a   Cao, Hongcui ^a   Yang, Jinfeng ^a   Pan, Qiaoling ^a   Ma, Jing ^a   Li, Jianzhou ^a   Li, Yanyuan ^a   Li, Jun ^a   Wang, Yingjie ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Hepatic differentiation; Liver injury; Mesenchymal stem cells; Transplantation; Umbilical cord blood

Indexed keywords

5' NUCLEOTIDASE; ADAPALENE; ALPHA FETOPROTEIN; BETA1 INTEGRIN; CYTOKERATIN 18; CYTOKERATIN 19; ENDOGLIN; EOSIN; GALACTOSAMINE; HEMATOXYLIN; HUMAN ALBUMIN; LIPOPOLYSACCHARIDE; THY 1 ANTIGEN;

ALU SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL REGENERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; FLOW CYTOMETRY; FULMINANT HEPATIC FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; UMBILICAL CORD BLOOD;

ALBUMINS; ALPHA-FETOPROTEINS; ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; GENE EXPRESSION; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; MESENCHYMAL STEM CELLS; MICE; MICE, SCID;

MUS;

EID: 84862292901     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.156     Document Type: Article

References (34)

1. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S.M., Mukhachev V., Lavroukov A., Kon E., Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 2001, 344:385-386.
2. Kadereit S., Deeds L.S., Haynesworth S.E., Koc O.N., Kozik M.M., Szekely E., Daum-Woods K., Goetchius G.W., Fu P., Welniak L.A., Murphy W.J., Laughlin M.J. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer. Stem Cells 2002, 20:573-582.
3. Fouillard L., Bensidhoum M., Bories D., Bonte H., Lopez M., Moseley A.M., Smith A., Lesage S., Beaujean F., Thierry D., Gourmelon P., Najman A., Gorin N.C. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003, 17:474-476.
4. Rao M.S., Mattson M.P. Stem cells and aging: expanding the possibilities. Mech. Ageing Dev. 2001, 122:713-734.
5. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
6. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 2002, 30:896-904.
7. Bieback K., Kern S., Kluter H., Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem cells 2004, 22:625-634.
8. Gang E.J., Hong S.H., Jeong J.A., Hwang S.H., Kim S.W., Yang I.H., Ahn C., Han H., Kim H. In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2004, 321:102-108.
9. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103:1669-1675.
10. Kim S.M., Lim J.Y., Park S.I., Jeong C.H., Oh J.H., Jeong M., Oh W., Park S.H., Sung Y.C., Jeun S.S. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res. 2008, 68:9614-9623.
11. Kim E.S., Chang Y.S., Choi S.J., Kim J.K., Yoo H.S., Ahn S.Y., Sung D.K., Kim S.Y., Park Y.R., Park W.S. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Respir. Res. 2011, 12:108.
12. Zanier E.R., Montinaro M., Vigano M., Villa P., Fumagalli S., Pischiutta F., Longhi L., Leoni M.L., Rebulla P., Stocchetti N., Lazzari L., De Simoni M.G. Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit. Care Med. 2011, 39:2501-2510.
13. Luo G., Cheng W., He W., Wang X., Tan J., Fitzgerald M., Li X., Wu J. Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood. Wound Repair Regen. 2010, 18:506-513.
14. Nagano M., Kimura K., Yamashita T., Ohneda K., Nozawa D., Hamada H., Yoshikawa H., Ochiai N., Ohneda O. Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair. Stem Cells Dev. 2010, 19:1195-1210.
15. Lee E.J., Choi E.K., Kang S.K., Kim G.H., Park J.Y., Kang H.J., Lee S.W., Kim K.H., Kwon J.S., Lee K.H., Ahn Y., Lee H.J., Cho H.J., Choi S.J., Oh W.I., Park Y.B., Kim H.S. N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction. Mol. Ther. 2012, 20:155-167.
16. Lim J.Y., Jeong C.H., Jun J.A., Kim S.M., Ryu C.H., Hou Y., Oh W., Chang J.W., Jeun S.S. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res. Ther. 2011, 2:38.
17. Shankar S.K. Human umbilical cord blood-derived mesenchymal stem cells and their effect on gliomas. Neurol. India 2011, 59:226-228.
18. Lee J.H., Chung W.H., Kang E.H., Chung D.J., Choi C.B., Chang H.S., Hwang S.H., Han H., Choe B.Y., Kim H.Y. Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury. J. Neurol. Sci. 2011, 300:86-96.
19. Lee H.J., Lee J.K., Lee H., Shin J.W., Carter J.E., Sakamoto T., Jin H.K., Bae J.S. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci. Lett. 2010, 481:30-35.
20. Shi L.L., Liu F.P., Wang D.W. Transplantation of human umbilical cord blood mesenchymal stem cells improves survival rates in a rat model of acute hepatic necrosis. Am. J. Med. Sci. 2011, 342:212-217.
21. Lee M.J., Jung J., Na K.H., Moon J.S., Lee H.J., Kim J.H., Kim G.I., Kwon S.W., Hwang S.G., Kim G.J. Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. J. Cell. Biochem. 2010, 111:1453-1463.
22. Campard D., Lysy P.A., Najimi M., Sokal E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008, 134:833-848.
23. Yan Y., Xu W., Qian H., Si Y., Zhu W., Cao H., Zhou H., Mao F. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int. 2009, 29:356-365.
24. Abdallah B.M., Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008, 15:109-116.
25. Xiong Q., Hase K., Tezuka Y., Namba T., Kadota S. Acteoside inhibits apoptosis in d-galactosamine and lipopolysaccharide-induced liver injury. Life Sci. 1999, 65:421-430.
26. Galanos C., Freudenberg M.A., Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 1979, 76:5939-5943.
27. Malhi H., Irani A.N., Gagandeep S., Gupta S. Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J. Cell Sci. 2002, 115:2679-2688.
28. Pathil A., Warth A., Chamulitrat W., Stremmel W. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFalpha-induced liver injury. J. Hepatol. 2011, 54:674-684.
29. Moschen A.R., Gerner R., Schroll A., Fritz T., Kaser A., Tilg H. A key role for Pre-B cell colony-enhancing factor in experimental hepatitis. Hepatology 2011, 54:675-686.
30. Maijenburg M.W., van der Schoot C.E., Voermans C. Mesenchymal stromal cell migration: possibilities to improve cellular therapy. Stem Cells Dev. 2012, 21:19-29.
31. Mouiseddine M., Francois S., Semont A., Sache A., Allenet B., Mathieu N., Frick J., Thierry D., Chapel A. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br. J. Radiol. 2007, 80(Spec No 1):S49-55.
32. Schoeberlein A., Mueller M., Reinhart U., Sager R., Messerli M., Surbek D.V. Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model. Am. J. Obstet. Gynecol. 2011, 205. 277 e271-276.
33. Jung Y.J., Ryu K.H., Cho S.J., Woo S.Y., Seoh J.Y., Chun C.H., Yoo K., Moon I.H., Han H.S. Syngenic bone marrow cells restore hepatic function in carbon tetrachloride-induced mouse liver injury. Stem Cells Dev. 2006, 15:687-695.
34. Ohgushi H., Caplan A.I. Stem cell technology and bioceramics: from cell to gene engineering. J. Biomed. Mater. Res. 1999, 48:913-927.